Biomarkers and Translational Tools (BTT) Community

Mission Statement:

The Biomarkers & Translational Tools (BTT) Community seeks to promote the use and advancement of biomarkers and other translational tools for optimization of drug development and patient care through the dissemination of knowledge and engagement of BTT members.

Vision Statement:
BTT envisions a Community of biomarker leaders and enthusiasts at all career stages whom the clinical pharmacology and translational science field turns to for expertise and support.

Rhythm of Business
  • Monthly leaders’ and steering committee meetings.
  • Weekly social media communications on recent developments relevant to the field.
  • Educational and networking opportunities via periodic webinars, Annual Meeting activities, and position papers.
For More Information on Getting Involved:
A Oni-Orisan

Akinyemi Oni-Orisan, PharmD, PhD

Community Chair


M Burian

Maria Burian, MD, PhD

Community Vice Chair


Mari Cayabyab, PharmD

Community Vice Chair


Steering Committee

Ryan Funk, Pharm D, PhD
Nithya Srinivas, PhD
Lakshmi Manasa Chekka, PharmD
Mai Mehanna, MS
Tien Truong, PharmD, PhD
Photo Gallery
Recent News
  • FDA Approves KERENDIA (Finerenone) to Reduce the Risk of Sustained EGFR Decline, End Stage Kidney Disease, Cardiovascular Death, Non-Fatal Myocardial Infarction, and Hospitalization for Heart Failure in Adult Patients with CKD Associated with T2D
    July 23, 2021
  • FDA and Duke-Margolis Announce a Public Workshop Entitled “Pharmacodynamic Biomarkers for Biosimilar Development and Approval” for September 20 – 21, 2021
    July 23, 2021
  • CTS Students and Trainees Step Into the Spotlight
    July 20, 2021
Contact Us